ciglitazone has been researched along with Airway Remodeling in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Airway Remodeling: The structural changes in the number, mass, size and/or composition of the airway tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciglitazone has been shown to be dependent on NF-κB- and STAT3-related pathways, thus, the PPAR-γ agonist may have therapeutic potential for the treatment of airway remodelling in asthma." | 1.91 | Anti-fibrotic effect of ciglitazone in HRV-induced airway remodelling cell model. ( Pawliczak, R; Wieczfinska, J, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wieczfinska, J | 1 |
| Pawliczak, R | 1 |
1 other study available for ciglitazone and Airway Remodeling
| Article | Year |
|---|---|
Anti-fibrotic effect of ciglitazone in HRV-induced airway remodelling cell model.
Topics: Airway Remodeling; Asthma; Fibrosis; Heart Rate; Humans; NF-kappa B; PPAR gamma; Rhinovirus; Thiazol | 2023 |